company background image
A092040 logo

Amicogen KOSDAQ:A092040 Stock Report

Last Price

₩3.84k

Market Cap

₩216.5b

7D

-4.4%

1Y

-36.7%

Updated

20 Nov, 2024

Data

Company Financials

Amicogen, Inc.

KOSDAQ:A092040 Stock Report

Market Cap: ₩216.5b

A092040 Stock Overview

Operates as an industrial biotechnology company in South Korea and internationally. More details

A092040 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Risk Analysis

Debt is not well covered by operating cash flow

Earnings have declined by 44.8% per year over past 5 years

Shareholders have been diluted in the past year


Amicogen, Inc. Competitors

S.Biomedics

KOSDAQ:A304360

₩281.9b

CG Invites

KOSDAQ:A083790

₩195.3b

NIBEC

KOSDAQ:A138610

₩160.7b

CORESTEMCHEMON

KOSDAQ:A166480

₩279.8b

Price History & Performance

Summary of all time highs, changes and price drops for Amicogen
Historical stock prices
Current Share Price₩3,835.00
52 Week High₩9,400.00
52 Week Low₩3,700.00
Beta1.01
11 Month Change-12.54%
3 Month Change-24.06%
1 Year Change-36.66%
33 Year Change-74.30%
5 Year Change-70.10%
Change since IPO-46.64%

Recent News & Updates

Revenues Working Against Amicogen, Inc.'s (KOSDAQ:092040) Share Price

Nov 11
Revenues Working Against Amicogen, Inc.'s (KOSDAQ:092040) Share Price

Little Excitement Around Amicogen, Inc.'s (KOSDAQ:092040) Revenues As Shares Take 27% Pounding

Jun 27
Little Excitement Around Amicogen, Inc.'s (KOSDAQ:092040) Revenues As Shares Take 27% Pounding

Does Amicogen (KOSDAQ:092040) Have A Healthy Balance Sheet?

Jun 19
Does Amicogen (KOSDAQ:092040) Have A Healthy Balance Sheet?

Amicogen, Inc. (KOSDAQ:092040) Held Back By Insufficient Growth Even After Shares Climb 39%

Mar 21
Amicogen, Inc. (KOSDAQ:092040) Held Back By Insufficient Growth Even After Shares Climb 39%

Recent updates

Revenues Working Against Amicogen, Inc.'s (KOSDAQ:092040) Share Price

Nov 11
Revenues Working Against Amicogen, Inc.'s (KOSDAQ:092040) Share Price

Little Excitement Around Amicogen, Inc.'s (KOSDAQ:092040) Revenues As Shares Take 27% Pounding

Jun 27
Little Excitement Around Amicogen, Inc.'s (KOSDAQ:092040) Revenues As Shares Take 27% Pounding

Does Amicogen (KOSDAQ:092040) Have A Healthy Balance Sheet?

Jun 19
Does Amicogen (KOSDAQ:092040) Have A Healthy Balance Sheet?

Amicogen, Inc. (KOSDAQ:092040) Held Back By Insufficient Growth Even After Shares Climb 39%

Mar 21
Amicogen, Inc. (KOSDAQ:092040) Held Back By Insufficient Growth Even After Shares Climb 39%

With EPS Growth And More, Amicogen (KOSDAQ:092040) Is Interesting

Mar 23
With EPS Growth And More, Amicogen (KOSDAQ:092040) Is Interesting

Should Amicogen (KOSDAQ:092040) Be Disappointed With Their 24% Profit?

Mar 05
Should Amicogen (KOSDAQ:092040) Be Disappointed With Their 24% Profit?

Is Amicogen (KOSDAQ:092040) A Risky Investment?

Feb 15
Is Amicogen (KOSDAQ:092040) A Risky Investment?

What Kind Of Investors Own Most Of Amicogen, Inc. (KOSDAQ:092040)?

Jan 31
What Kind Of Investors Own Most Of Amicogen, Inc. (KOSDAQ:092040)?

Could The Market Be Wrong About Amicogen, Inc. (KOSDAQ:092040) Given Its Attractive Financial Prospects?

Jan 14
Could The Market Be Wrong About Amicogen, Inc. (KOSDAQ:092040) Given Its Attractive Financial Prospects?

Amicogen (KOSDAQ:092040) Is Growing Earnings But Are They A Good Guide?

Dec 30
Amicogen (KOSDAQ:092040) Is Growing Earnings But Are They A Good Guide?

Is Now The Time To Put Amicogen (KOSDAQ:092040) On Your Watchlist?

Dec 15
Is Now The Time To Put Amicogen (KOSDAQ:092040) On Your Watchlist?

Did You Miss Amicogen's (KOSDAQ:092040) 37% Share Price Gain?

Nov 30
Did You Miss Amicogen's (KOSDAQ:092040) 37% Share Price Gain?

Shareholder Returns

A092040KR BiotechsKR Market
7D-4.4%-4.0%-0.7%
1Y-36.7%23.9%-4.1%

Return vs Industry: A092040 underperformed the KR Biotechs industry which returned 23.9% over the past year.

Return vs Market: A092040 underperformed the KR Market which returned -4.1% over the past year.

Price Volatility

Is A092040's price volatile compared to industry and market?
A092040 volatility
A092040 Average Weekly Movement7.8%
Biotechs Industry Average Movement8.0%
Market Average Movement5.6%
10% most volatile stocks in KR Market11.5%
10% least volatile stocks in KR Market2.7%

Stable Share Price: A092040 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A092040's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000225Piao Zhewww.amicogen.com

Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company offers bio-ingredients, such as N-acetylglucosamine for skin moisturizing and joint health; pinitol/D-chiro-inositol; collagen peptide and collagen tripeptide for skin and health; chitoslim and chitosan oligosaccharides, as well as fucoxanthin, curezyme, food enzyme, and bamboo salt. It also offers specialty enzymes, including CX, SP, etc. for pharmaceutical, food, and feed sectors.

Amicogen, Inc. Fundamentals Summary

How do Amicogen's earnings and revenue compare to its market cap?
A092040 fundamental statistics
Market cap₩216.52b
Earnings (TTM)-₩36.91b
Revenue (TTM)₩158.98b

1.3x

P/S Ratio

-5.7x

P/E Ratio

Is A092040 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A092040 income statement (TTM)
Revenue₩158.98b
Cost of Revenue₩108.48b
Gross Profit₩50.51b
Other Expenses₩87.41b
Earnings-₩36.91b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-673.28
Gross Margin31.77%
Net Profit Margin-23.21%
Debt/Equity Ratio84.0%

How did A092040 perform over the long term?

See historical performance and comparison